在患有埃布斯坦异常的孕妇中,孕妇的心脏和周产期结果
相关实验视频
Updated: Sep 13, 2025

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.5K
Gianna L Wilkie1, Rahi Patel2, Lara Kovell3
1Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, UMASS Chan School of Medicine, Worcester, Massachusetts.
The American journal of cardiology
|July 25, 2025
概括
患有埃布斯坦异常的孕妇面临显著的心脏风险,包括较高的心律失常和心力衰竭率. 这种罕见的先天性心脏病需要在怀孕期间进行仔细监测,以改善孕产妇和周围产生的结果.
科学领域:
- 心脏病学 心脏病学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 埃布斯坦异常是一种罕见的先天性心脏病.
- 关于其在怀孕期间的影响的数据有限.
- 了解怀孕后果对于受影响的个体至关重要.
研究的目的:
- 描述患有埃布斯坦异常症的孕妇心脏和周产期结果.
- 将结果与其他先天性心脏病和无先天性心脏病组进行比较.
- 通过心律失常状态对埃布斯坦异常结果进行分层.
主要方法:
- 使用史诗宇宙数据集 (美国医院) 的回顾性队列研究.
- 确定了患有埃布斯坦异常的怀孕 (2021年7月至2025年3月).
- 与对照组比较人口统计,心脏和围产期结局.
主要成果:
- 确定了261名患有埃布斯坦异常和怀孕的个人.
- 在人口统计学,心脏结果 (心律失常,心力衰竭) 和围产期结果方面观察到显著的差异.
- 41%患有埃布斯坦异常的孕妇患有心律不整,18%患有心力衰竭.
结论:
- 埃布斯坦异常与怀孕期间存在的大量心脏风险有关.
- 心律不整和心力衰竭是严重的并发症.
- 对于这一群体,需要进一步的研究和监测.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K

